mug121 Antibody

What is mug121 Antibody and what organism does it target?

mug121 Antibody (product code CSB-PA791041XA01SXV) is a polyclonal antibody raised in rabbits against the recombinant mug121 protein from Schizosaccharomyces pombe (strain 972 / ATCC 24843), commonly known as fission yeast. This antibody is specifically designed for research applications involving S. pombe and has been affinity-purified to ensure specificity for the target protein. The antibody is delivered in liquid form, containing 50% glycerol with 0.01M PBS (pH 7.4) and 0.03% Proclin 300 as a preservative. Its applications have been validated for ELISA and Western blot techniques, making it suitable for protein detection and quantification studies in fission yeast models .

How does mug121 Antibody differ from other types of research antibodies?

Unlike monoclonal antibodies that recognize a single epitope on an antigen, mug121 Antibody is polyclonal, meaning it contains a heterogeneous mixture of antibodies that bind to multiple epitopes on the mug121 protein target. This characteristic provides both advantages and limitations compared to monoclonal antibodies like those described in other research contexts (such as anti-MUC1 or anti-SARS-CoV-2 antibodies). The polyclonal nature increases sensitivity for detection applications by allowing signal amplification through multiple binding sites, but may introduce more variability between production lots. Additionally, unlike therapeutic antibodies that undergo extensive humanization processes, mug121 Antibody is specifically intended for research use only and should not be employed in diagnostic or therapeutic applications .

What are the validated applications for mug121 Antibody?

Based on the manufacturer's specifications, mug121 Antibody has been validated for enzyme-linked immunosorbent assay (ELISA) and Western blot (WB) applications. In ELISA applications, this antibody can be used to detect and quantify mug121 protein in samples from S. pombe. For Western blot applications, it enables visualization of the protein following gel electrophoresis and membrane transfer. The antibody's specific binding to mug121 makes it valuable for studies investigating protein expression, localization, and function in fission yeast systems. When designing experiments with this antibody, researchers should consider that while these applications have been validated, optimization may be required for specific experimental conditions and protocols .

What are the optimal storage conditions for mug121 Antibody to maintain activity?

To maintain optimal activity of mug121 Antibody, proper storage conditions are crucial. Upon receipt, the antibody should be stored at either -20°C or -80°C for long-term preservation. The antibody is supplied in a stabilizing buffer containing 50% glycerol, which prevents freezing damage at -20°C. Repeated freeze-thaw cycles significantly diminish antibody functionality through protein denaturation and aggregation; therefore, it is advisable to aliquot the antibody into smaller volumes upon receipt before freezing. When handling the antibody, always keep it on ice and return to storage promptly after use. The presence of preservative (0.03% Proclin 300) helps maintain stability, but does not eliminate the need for proper temperature control. For projects requiring frequent antibody use, a working aliquot can be maintained at 4°C for approximately 1-2 weeks, while keeping the remainder frozen for longer-term storage .

How should researchers determine the optimal dilution for mug121 Antibody in Western blot applications?

Determining the optimal dilution for mug121 Antibody in Western blot applications requires a systematic titration approach. Begin with a dilution series (e.g., 1:500, 1:1000, 1:2000, 1:5000) using positive control samples containing the mug121 protein from S. pombe. The optimal dilution will provide a clear specific band with minimal background. Important considerations include: (1) Sample preparation - ensure proper cell lysis and protein denaturation for the exposure of epitopes; (2) Blocking conditions - optimize to reduce non-specific binding; (3) Incubation time and temperature - typically overnight at 4°C or 1-2 hours at room temperature; (4) Detection method - choose appropriate secondary antibody and detection system. Since this is a polyclonal antibody, batch-to-batch variation may occur, necessitating optimization with each new lot. Document the optimal conditions in your laboratory protocols to ensure consistency across experiments and between researchers. When troubleshooting weak signals, consider longer exposure times or higher antibody concentrations, while addressing high background by increasing washing steps or further diluting the antibody .

What controls should be included when using mug121 Antibody in experimental protocols?

Implementing appropriate controls is essential for validating results obtained with mug121 Antibody. For robust experimental design, include the following controls: (1) Positive control - wild-type S. pombe lysate expressing mug121 protein; (2) Negative control - mug121 knockout strain or species not expressing the target protein; (3) Primary antibody control - omit primary antibody while maintaining all other steps to assess secondary antibody specificity; (4) Loading control - detect a housekeeping protein (e.g., actin, GAPDH) to normalize protein loading; (5) Pre-immune serum control - if available, use the pre-immune serum from the same rabbit to assess non-specific binding. For advanced applications, consider including a peptide competition assay where the antibody is pre-incubated with excess antigen peptide to confirm binding specificity. These controls help distinguish specific signals from artifacts and validate that observed results are attributable to mug121 protein detection rather than experimental variables or non-specific interactions .

How can mug121 Antibody be adapted for immunoprecipitation studies of protein complexes?

While mug121 Antibody is primarily validated for ELISA and Western blot applications, adapting it for immunoprecipitation (IP) studies requires specific optimization steps. Begin by covalently coupling the antibody to protein A/G beads using crosslinkers like BS3 or DMP to prevent antibody co-elution with the target protein. For cell lysate preparation, use gentle lysis buffers (e.g., 150mM NaCl, 50mM Tris pH 7.5, 1% NP-40, 0.5% sodium deoxycholate) supplemented with protease inhibitors to preserve protein-protein interactions. Pre-clear lysates with beads alone to reduce non-specific binding. Optimize antibody-to-lysate ratios through preliminary experiments, typically starting with 2-5μg antibody per 500μg protein lysate. After overnight incubation at 4°C, perform stringent washing steps while balancing the need to remove non-specific interactions without disrupting genuine protein complexes. Elute bound proteins using either low pH buffers or by boiling in SDS sample buffer, depending on downstream applications. Verify successful immunoprecipitation by Western blot analysis using a portion of the eluted material. For studying protein-protein interactions, consider performing reciprocal co-immunoprecipitation with antibodies against suspected interaction partners to confirm results .

What methodological approaches enable detection of post-translational modifications of mug121 protein?

Investigating post-translational modifications (PTMs) of mug121 protein requires sophisticated methodological approaches beyond standard Western blot analysis. To detect phosphorylation, researchers can employ Phos-tag™ acrylamide gels that specifically retard the migration of phosphorylated proteins, followed by detection with mug121 Antibody. Alternatively, immunoprecipitate mug121 using the antibody and probe with phospho-specific antibodies (anti-phosphoserine, -threonine, or -tyrosine). For comprehensive PTM profiling, implement mass spectrometry-based approaches: immunoprecipitate mug121 protein from S. pombe lysates, perform in-gel or in-solution digestion with proteases (typically trypsin), and analyze the resulting peptides using LC-MS/MS. Enrichment strategies for specific PTMs include IMAC (Immobilized Metal Affinity Chromatography) for phosphopeptides or lectin affinity chromatography for glycosylated residues. When analyzing results, compare PTM profiles under different experimental conditions (e.g., cell cycle stages, stress responses) to determine functional significance. Additionally, site-directed mutagenesis of putative modification sites followed by functional assays can validate the biological importance of identified PTMs. Remember that native protein extraction conditions are critical for preserving labile modifications, so optimize lysis buffers to include appropriate phosphatase and deubiquitinase inhibitors .

How can researchers utilize mug121 Antibody for studying protein localization through immunofluorescence microscopy?

While not explicitly validated for immunofluorescence, adapting mug121 Antibody for subcellular localization studies requires careful optimization. Begin by testing different fixation methods (4% paraformaldehyde, methanol, or glutaraldehyde) to determine which best preserves epitope accessibility while maintaining cellular architecture. For S. pombe cells, enzymatic digestion of the cell wall may be necessary to improve antibody penetration. Implement rigorous blocking procedures (5% BSA or normal serum from the secondary antibody species) to minimize background fluorescence. Test a range of antibody dilutions (starting with 1:100-1:500) and incubation conditions (overnight at 4°C versus 1-2 hours at room temperature). Select secondary antibodies with appropriate fluorophores that match your microscopy setup, ensuring minimal spectral overlap if performing multi-color imaging. Include DAPI staining for nuclear visualization as a reference point. Critical controls include: (1) secondary-only control to assess background; (2) pre-immune serum control if available; (3) peptide competition control; and (4) comparison with mug121 gene deletion strains. For colocalization studies, combine with markers for specific organelles (e.g., mitochondria, endoplasmic reticulum) using antibodies raised in different species to avoid cross-reactivity. Advanced applications may include super-resolution microscopy techniques like STED or STORM for nanoscale localization precision .

What strategies can resolve non-specific binding issues when using mug121 Antibody in Western blots?

Non-specific binding is a common challenge when working with polyclonal antibodies like mug121 Antibody. To systematically address this issue, implement the following troubleshooting strategies: (1) Increase the blocking stringency by using 5% BSA or 5% non-fat dry milk in TBS-T, or consider commercial blocking reagents specifically designed to reduce background; (2) Optimize antibody dilution - try a series of higher dilutions to reduce non-specific interactions while maintaining specific signal; (3) Add 0.1-0.5% Tween-20 or 0.1% Triton X-100 to the antibody dilution buffer to reduce hydrophobic interactions; (4) Increase wash duration and frequency between antibody incubations (4-5 washes for 5-10 minutes each); (5) Pre-absorb the antibody with lysate from a negative control sample (e.g., knockout strain) to remove antibodies that recognize non-target proteins; (6) Use higher stringency wash buffers by increasing salt concentration (up to 500mM NaCl) in TBS-T. For persistent non-specific bands, consider modifying the membrane transfer conditions or switching membrane types (PVDF versus nitrocellulose). Document all optimization steps and maintain consistent protocols once optimal conditions are established. Remember that some level of non-specific binding may be unavoidable with polyclonal antibodies, so focus on clearly distinguishing specific bands based on their molecular weight and comparison with positive and negative controls .

How should researchers interpret conflicting results between antibody-based detection methods?

When facing conflicting results between different antibody-based detection methods (e.g., Western blot showing different results than ELISA), a systematic analytical approach is essential. First, recognize that each technique detects proteins in different states: Western blot under denaturing conditions versus ELISA often under native conditions, potentially affecting epitope accessibility. Perform a thorough technical assessment: (1) Verify protein extraction methods are appropriate for each technique; (2) Ensure sample preparation preserves the target protein's integrity; (3) Check that positive and negative controls perform as expected in each assay; (4) Consider cross-reactivity with related proteins in complex samples. For quantitative discrepancies, examine whether signal saturation has occurred in either method. If Western blot shows multiple bands while ELISA indicates high specificity, investigate whether the target protein undergoes post-translational modifications or exists in multiple isoforms. To resolve conflicts, consider orthogonal approaches such as mass spectrometry for definitive protein identification, or genetic approaches like analyzing knockout strains. Document all experimental variables including buffer compositions, incubation times, and detection methods. Finally, consult literature for reported challenges with the specific protein target and consider reaching out to the antibody manufacturer for technical support .

What methodological considerations apply when quantifying relative mug121 protein levels in comparative studies?

Quantifying relative mug121 protein levels in comparative studies requires meticulous attention to methodological details to ensure accurate results. First, standardize protein extraction procedures across all samples to maintain consistent recovery efficiency. For Western blot quantification: (1) Determine the linear dynamic range of detection for mug121 Antibody through a standard curve using recombinant protein or calibrated samples; (2) Load equal total protein amounts verified through protein concentration assays and confirmed by housekeeping protein detection; (3) Include an internal calibration sample on each gel to normalize between blots; (4) Use digital image acquisition with appropriate exposure times that avoid pixel saturation; (5) Employ scientific image analysis software (e.g., ImageJ) with consistent quantification parameters. For ELISA quantification, develop a standard curve using recombinant mug121 protein if available, and ensure all samples fall within the linear range of the assay. When comparing protein levels across different experimental conditions, process all samples simultaneously to minimize technical variability. Statistical analysis should account for biological replicates (n≥3) and technical replicates. Report results as fold-changes relative to control conditions rather than absolute values, and include appropriate statistical tests (t-test, ANOVA) with measures of variability (standard deviation or standard error). Consider complementary approaches such as qRT-PCR to correlate protein levels with mRNA expression, while recognizing post-transcriptional regulation may lead to discrepancies .

What methodological differences exist when working with antibodies targeting yeast proteins versus human proteins?

Working with antibodies targeting yeast proteins like mug121 from S. pombe presents distinct methodological challenges compared to working with antibodies against human proteins. First, cell disruption techniques differ significantly due to the rigid cell wall of yeast, requiring mechanical disruption (glass beads, French press) or enzymatic digestion (zymolyase, lyticase) to efficiently release proteins while maintaining their native state. Buffer compositions need adjustment for yeast samples, often requiring higher salt concentrations (200-300mM) and specific detergents to solubilize yeast membrane proteins. For immunoprecipitation studies, researchers must optimize lysis conditions to account for compartmentalization within yeast cells that differs from mammalian cellular organization. Cross-reactivity considerations also differ; while antibodies against human proteins often need validation against multiple related human proteins, yeast-targeted antibodies require verification against related yeast species or strains. This is particularly important when studying conserved proteins with homologs in other organisms. Fixation protocols for immunofluorescence applications require significant modification for yeast cells, including specialized cell wall digestion steps not necessary for mammalian cells. Additionally, expression systems for producing recombinant proteins as standards or immunogens typically employ different vectors and host systems optimized for yeast proteins versus human proteins. These methodological differences necessitate specialized protocols when working with yeast-targeted antibodies, distinct from standardized methods developed for human protein research .

Technical Specifications of mug121 Antibody